Gastric and duodenal mucosal surface and Helicobacter pylori surface proteins and enzymes

The gastric and duodenal mucosal surface and Helicobacter pylori surface proteins and enzymes constitute a multi-component therapeutic target for bismuth-based drugs. Bismuth complexes, such as bismuth subsalicylate and colloidal bismuth subcitrate, exert their effects locally within the gastrointestinal tract (NIH, 2023). They provide cytoprotection by forming a physical barrier over ulcers and erosions, shielding the tissue from gastric acid and pepsin while enhancing mucosal protective factors like prostaglandins and bicarbonate (NIH, 2023). Simultaneously, bismuth exhibits direct antimicrobial activity against H. pylori by inhibiting key enzymes such as urease and alcohol dehydrogenase, disrupting cell wall integrity, and interfering with bacterial iron uptake and ATP synthesis (NIH, 1992; ASM, 2015). Bismuth also downregulates virulence factors like CagA and VacA and disrupts flagella assembly, which are critical for bacterial colonization (NIH, 2023). This dual mechanism of action makes bismuth an essential component of quadruple therapy for H. pylori eradication, helping to overcome antibiotic resistance (NIH, 2015). Clinically, these agents are used to treat peptic ulcers, chronic gastritis, and dyspepsia, while also serving as a preventive measure against H. pylori-associated gastric cancer. The target is unique because it involves both host tissue protection and pathogen-specific enzyme inhibition.

Other names

H. pylori ureaseH. pylori alcohol dehydrogenaseGastric mucosal barrierBismuth-binding proteinsH. pylori surface proteinsBismuth targets

Bismuth complexes exert a multifactorial effect by forming a physical protective coating over gastric and duodenal ulcers, which shields the mucosa from acid and pepsin (NIH, 2023). Simultaneously, they exhibit direct antimicrobial activity against Helicobacter pylori by inhibiting key enzymes such as urease and alcohol dehydrogenase, disrupting cell wall integrity, and interfering with bacterial iron uptake and ATP production (NIH, 1992; ASM, 2015).